Active-ingredient Dossier
Oxycodone Hydrochloride
Active-ingredient Dossier for Oxycodone Hydrochloride (opioid analgesic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ENDONE
- Brand: OXYCODONE SANDOZ
- Brand: OXYCONTIN
- Brand: OXYNORM
- Brand: TARGIN
- Brand: ARX-Oxycodone/Naloxone
- Therapeutic area: Pain Management
What is
Oxycodone Hydrochloride Oxycodone Hydrochloride is an opioid analgesic.
Australian brands containing
Oxycodone Hydrochloride — ENDONE — OXYCODONE SANDOZ — OXYCONTIN — OXYNORM — TARGIN — OXYCODONE — OXYCODONE BNM — OXYCODONE HCl — Oxycodone Juno — OXYCODONE-HAMELN — OXYNDONE
Therapeutic areas
Oxycodone Hydrochloride is registered in Pain & Anaesthesia (19 brands), Oncology (7 brands), and Pain Management (3 brands).
Sponsor landscape
The ingredient is marketed by Arrotex Pharmaceuticals, MedTAS, Mundipharma, Viatris, Boucher & Muir, and Maple Healthcare.
PBS and regulatory activity
Four brands containing Oxycodone Hydrochloride have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 July 2019, and the latest AusPAR was issued on 14 July 2016.